600222.SH
太龙药业
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 7.55
−3.70%Margins
Gross margin
27.9%
EBITDA margin
7.8%
EBIT margin
4.3%
Net margin
3.4%
FCF margin
-10.2%
3.8%
Return on equity
1.7%
Return on assets
3.1%
Return on invested capital
0.49x
Asset turnover
-CNY 161.4M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026